Valneva Announces Share and Voting Right Changes as of July 31, 2024

Valneva, a biopharmaceutical company based in France, has declared updates regarding its shares and voting rights effective as of July 31, 2024. The company is listed on the Euronext Paris regulated market, specifically in Compartment B.

The announcement, made on August 6, 2024, details the current number of shares and voting rights. Valneva has 139,276,901 ordinary shares, each with a par value of €0.15. The total number of theoretical voting rights, including suspended ones, stands at 155,894,329, while the number of exercisable voting rights is 155,770,007.

Key changes include the sale and transfer of shares. On July 18, 2024, 280 shares with double voting rights were sold. Between July 18 and July 23, 1,750,000 shares with double voting rights were transferred into bearer form. On July 29, double voting rights were granted to 29 additional ordinary shares.